Speakers

Blom

Kristin Blom

Uppsala University Hospital, Uppsala, Sweden

Sweden

Discussion

Birault

Veronique Birault

Crick Institute

Discussion

Bountra

Prof Chas Bountra

Oxford SGC - University of Oxford

Discussion

Breinlinger

Keith Breinlinger

Berkeley Lights

Discussion

Brierley

David Brierley

GSK

Discussion

bueno

Gloria bueno

Universidad de Castilla-La Mancha

Discussion

Ciulli

Alessio Ciulli

University of Dundee

Discussion

Coupland

Sarah Coupland

University of Liverpool

Discussion

Dabrowski

Michael Dabrowski

Pelago Bioscience

Discussion

Davis

Ben Davis

Oxford University

Discussion

Deml

Ludwig Deml

Lophius Bioscience

Discussion

Dive

Caroline Dive

Manchester University

Discussion

Docherty

Kevin Docherty

University of Aberdeen

Discussion

Elvassore

Nicola Elvassore

UCL

Discussion

Eyers

Patrick Eyers

University of Liverpool

Discussion

Frese

Kris Frese

Manchester University

Discussion

Gilham

David Gilham

Manchester Cancer Research Centre

Discussion

Grabowska

Anna Grabowska

University of Nottingham

Discussion

Green

Victoria Green

University of Hull

Discussion

Grimley

Rachel Grimley

AstraZeneca

Discussion

Groothuis

Geny Groothuis

Groningen Research Institute for Pharmacy

Discussion

Haddrick

Malcolm Haddrick

AstraZeneca

Discussion

Harling

John Harling

GSK

Discussion

Hassan

Dr Namir Hassan

Immunocore

Discussion

Hornberg

Ellinor Hornberg

AstraZeneca

Discussion

Jorgensen

Claus Jorgensen

Cancer Research UK Manchester Institute

Discussion

Kara

Bo Kara

GlaxoSmithKline

Discussion

Kettleborough

Katy Kettleborough

MRCT

Discussion

Krige

David Krige

ImmunoCore

Discussion

Larminie

Chris Larminie

GSK Stevenage

Discussion

Vivian Li

The Francis Crick Institute

Discussion

Lundback

Thomas Lundback

Karolinska Institutet

Discussion

Marxx

Uwe Marxx

TissUse

Discussion

Merritt

Andy Merritt

MRC Technology

Discussion

Michalovich

David Michalovich

GlaxoSmith Kline

Discussion

Milne

Dr Stuart Milne

Asymptote

Discussion

Moore

Jon Moore

Horizon Discovery

Discussion

Nordlund

Par Nordlund

Karolinska Institutet

Discussion

O'Neill

Paul O'Neill

University of Liverpool

Discussion

O'Neill

Luke O'Neill

Trinity College Dublin

Discussion

Ottman

Christian Ottman

Eindhoven

Discussion

Oumie

Assa Oumie

Cell & Gene Therapy Catapult

Discussion

Petreus

Tudor Petreus

Oncology iMed, AstraZeneca

Discussion

Pirmohamed

Munir Pirmohamed

Drug Safety in Drug Development - THURS

Discussion

Pourfazad

Farzin Pourfazad

Hubrecht Organoid Technology, HUB

Discussion

Pule

Martin Pule

UCL

Discussion

Ratni

Hasane Ratni

Roche

Discussion

Roberts

Michael Roberts

Synpromics

Discussion

Robinson

Carol Robinson

Omass Technologies Ltd

Discussion

Seiber

Stephan Seiber

TU Munich

Discussion

Shah

Gopi Shah

Cancer Institute, Cambridge

Discussion

Sinclair

Ian Sinclair

AstraZeneca

Discussion

Stubbs

Mark Stubbs

The Institute of Cancer Research (ICR)

Discussion

Tang

Dr Eric Tang

Tekbiomedical

Discussion

Tate

Ed Tate

Imperial College London

Discussion

TBC

TBC TBC

University

Discussion

Toldi

Gergely Toldi

MDQuest

Discussion

Trezise

Del Trezise

EssenBio

Discussion

Walker

Paul Walker

Cyprotex

Discussion

Ward

Simon Ward

University of Sussex

Discussion

Wehmeier

Oliver Wehmeier

Accellerate

Discussion

Wennerberg

Krister Wennerberg

Institute of Molecular Medicine Finland

Discussion

Wilkinson

Robert Wilkinson

Medimmune

Discussion

Wingfield

Jonathan Wingfield

AstraZeneca

Discussion

Wurch

Thierry Wurch

Servier

Discussion

Speakers

Green

Dr Clive Green

AstraZeneca

Discussion

Osanlou

Rostam Osanlou

Discussion

Ryder

Dr Stephanie Ryder

Cyprotex Discovery Ltd

Discussion